Tyson Foods, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Tyson Foods, Inc. trades at $54.78 (market cap $18.92B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Tyson Foods, Inc. is far larger — about 10.5× Vir Biotechnology Inc. Common Stock's market cap, and Tyson Foods, Inc. pays a 3.79% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tyson Foods, Inc. for 77 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| TSN | VIR | |
|---|---|---|
Market Cap | $18.92B | $1.80B |
Volume | 2,968,585 | 1,782,836 |
Sector | Consumer Staples | Health |
52-Week High | $68.75 | $11.78 |
52-Week Low | $50.47 | $5.12 |
Typical Hold Time | 77 Days | 0 Days |
Enterprise Value | $26.19B | $1.36B |
Dividend Yield | 3.79% | — |
Signals from Pluang's Aura AI — not financial advice
Tyson Foods (TSN) trades at $54.22, up 1.21% with a bullish technical signal despite recent volatility. The stock shows mixed earnings performance with two beats and one miss in recent quarters, while maintaining a 53% analyst buy rating. Current valuation metrics include a P/E of 33.2 and P/S of 0.34, with revenue growth projected to $55.7B in 2026. Recent corporate actions include consistent dividend payments of $0.51 per share.
Outlook remains cautiously optimistic with a $65.40 consensus price target representing 21% upside potential. Key risks include ongoing beef segment losses, securities investigations, and margin pressure. The company's ability to maintain dividends while addressing operational challenges will be critical for sustained shareholder value.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →